ACTINIUM PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $191.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-05-08
- ACTINIUM PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $191.00K, a 20.89% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $158.00K.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $648.00K, a 5.54% increase from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $614.00K, a 5.32% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $583.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|
| 2026-03-31 | $191.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $648.00K 10-K · filed 2026-03-30 | |
| 2025-03-31 | $158.00K 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $614.00K 10-K · filed 2026-03-30 | |
| 2023-12-31 | $583.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |